At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Symphion® Bipolar Hysteroscopic Tissue Resection Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Assess the Feasibility of the Symphion® Bipolar Hysteroscopic Tissue Resection System in an Office Environment
In Brief
A clinical study evaluating Symphion® Bipolar Hysteroscopic Tissue Resection System for Uterine Leiomyomas and Endometrial Polyps. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the safety and feasibility of using the Symphion system in an office setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUterine Leiomyomas, Endometrial Polyps
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartNov 2014
Primary CompletionMar 2015
Study CompletionApr 2015
First PostedAug 2015
TodayJul 2026
First PostedAug 11, 2015
Enrollment StartNov 1, 2014
Primary CompletionMar 1, 2015
Study CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.9 years ago
Interventions
Symphion® Bipolar Hysteroscopic Tissue Resection Systemdevice